This report discusses the need for an integrated and cyclical approach to managing health technology in order to mitigate clinical and financial risks, and ensure acceptable value for money.

This report reviews the important role of medicines in health sytems, describes recent trends in pharmaceutical expenditure and financing, and summarises the approaches used by OECD countries to determine coverage and pricing.

Applying a trans-disciplinary approach, this book provides a comprehensive, research-based guide to understanding, implementing, and strengthening sustainable community health in diverse international settings. By examining the interdependence of environmental, economic, public health, community wellbeing and development factors, the authors address the systemic factors impacting health disparities, inequality and social justice issues. The book analyzes strategies based on a partnership view of health, in which communities determine their health and wellness working alongside local, state and federal health agencies. Crucially, it demonstrates that communities are themselves health systems and their wellbeing capabilities affect the health of individuals and the collective alike. It identifies health indicators and tools that communities and policy makers can utilize to sustain truly inclusive health systems. This book offers a unique resource for researchers and practitioners working across psychology, mental health, rehabilitation, public health, epidemiology, social policy, healthcare and allied health.

This report explores how data and digital technology can help achieve policy objectives and drive positive transformation in the health sector while managing new risks such as privacy, equity and implementation costs. It examines the following topics: improving service delivery models; empowering people to take an active role in their health and their care; improving public health; managing biomedical technologies; enabling better collaboration across borders; and improving health system governance and stewardship.

This edited book focuses on the role and use of emerging technologies within the healthcare sector. This text draws on expertise from leading practitioners and researchers who either utilize and/or are at the forefront of researching with emerging technology in anticipation of enhancing patient outcomes. Emerging Technologies in Healthcare: Interpersonal and Client-Based Perspectives focuses on the role of emerging technologies in society and how it may enhance medical treatment, management, and rehabilitation of service users. It offers expert perspectives on topics covering emerging technological advances and how they are being incorporated into healthcare, but also critically appraises forthcoming implementation. The editors draw from recent publications and the growing narrative surrounding technological advances, notably telerehabilitation, virtual reality, augmentation, and mHealth. Subsequent chapters focus on these, coupled with other emerging technologies, providing detailed insight into how these can either enhance and/or hinder patient/service user outcomes. Each chapter explores the multifaceted use and application of each emerging technology, that impacts on diagnosis, treatment, and (self-) management of individuals. For example, can emerging technology really facilitate patient diagnosis, improve, or remove practitioner–patient interactions, provide sound rehabilitation, and treat/monitor mental health conditions? This edited volume encompasses an array of emerging technologies that will remain pertinent to caregivers, families, practitioners, service users and policymakers. This is not a text on emerging technology alone but on its societal implications, accompanied by ethical, altruistic, and moral examples for such advances within the healthcare field. It is targeted that this text will enhance and offer original discussions surrounding the interconnectivity of technology and medicine, rehabilitation, and patient care.

The current era of incredible innovations has made science and technology one of the most powerful tools to meet the goals of incremental prosperity for humans and sustainable development. The development of the biotech industry in any given country is shaped by the characteristics of the technology—particularly its close relation to scientific knowledge—and by country-specific factors—the level and nature of the scientific knowledge base, the institutional set-up, and the role assumed by the government—which influence the country's ability to exploit new opportunities and appropriate the respective results. This book presents an integrated approach for sustained innovation in various areas of biotechnology. Focusing mainly on the industrial, socio-economic and legal implications of biotechnological advances, it examines in detail not only the implications of IPR in omics-based research but also the ethical and intellectual standards and how these can be developed for sustained innovation. Integrating science and business, it offers a peek behind the scenes of the biotech industry and provides a comprehensive analysis of the foundations of the present day industry for students and professionals alike. The book is divided into three parts: Food and Agricultural BiotechnologyIndustrial BiotechnologyPharmaceutical Biotechnology

Ensuring equity in healthcare is the main concern of health policymakers in order to provide a sustainable health system. This concern is more prominent in developing countries due to the scarcity of resources. This book provides a comprehensive analysis and discussion on the distributive pattern of out-of-pocket pharmaceutical expenditures under the health reforms in Turkey and makes comparisons with pharmerging countries. Turkey’s health reforms began in 2003 to address shortcomings related to financial protection and to improve health outcomes and the quality of healthcare services. The primary motivation was to ensure equity in the distribution of health resources, and this transformation process led to profound changes in how these resources were used, and in health financing in general. However, there is a lack of knowledge regarding the long-term effect of health reforms on the distribution patterns of health expenditures and health service use. This book offers a thorough equity analysis of the health financing system, affected by this health transformation program. Index and curve approaches are used in the equity analysis of pharmaceutical expenditures. The book examines the long-term effects of health system regulations on the health spending characteristics of households and improves the current understanding of equity in this context. It includes extensive international comparisons of healthcare services across a range of developing countries and highlights the significance of ensuring equity for emerging economies. The author explores the existing evidence as well as future research directions and provides policy and planning advice for health policymakers to contribute to establishing a more equal health system design. Additionally, the book will be of interest to scholars and professionals in the fields of health economics, public health management and health financing.

This book introduces the concept of ‘healthy healthcare’ and posits that this new concept is necessary in light of a shortage of healthcare staff in the near future. Healthy healthcare implies that healthcare systems are designed, managed and financed in balance with the available resources to improve workers’ health and performance. Ultimately, a balanced perspective taking into account the patient, the staff and the complex healthcare system will lead to a more resource-efficient delivery of high-quality healthcare services. The book synthesizes evidence-based practice and research on the links between healthcare services, employee health and wellbeing, and quality of healthcare from an interdisciplinary perspective. Written by leading experts in this rapidly expanding field of inquiry, this is the first book ever compiled on the subject with such scope and breadth. It discusses how to conduct interventions and research on healthy healthcare with different populations and settings. The chapters critically examine the links between these pillars; and identify research gaps in both methodology and content from the perspectives of psychology, medicine, nursing, economy, law, technology, management and more. This innovative book is of interest to researchers and students of health sciences, public health, health economics and allied disciplines, as well as to stakeholders in the healthcare industry. Chapter 24 of this book is available open access under a CC-By NC-ND 4.0 license at link.springer.com

The 5th World Congress on Genetics, Geriatrics, and Neurodegenerative Diseases Research (GeNeDis 2022) focuses on the latest major challenges in scientific research, new drug targets, the development of novel biomarkers, new imaging techniques, novel protocols for early diagnosis of neurodegenerative diseases, and several other scientific advances, with the aim of better, safer, and healthier aging. This volume focuses on the sessions from the conference on Neuroscientific Advances.

With the adoption of the 2030 Agenda for Sustainable Development, all nations committed to a set of universal, integrated and transformational goals and targets, the Sustainable Development Goals (SDGs). Translating the new vision of the SDGs into action is a major challenge.